Avidity Biosciences (RNA) Stock Chart & Stock Price History → This unknown company solves the biggest issue with AI (From Manward Press) (Ad) Free RNA Stock Alerts $26.61 +0.29 (+1.10%) (As of 05/29/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrends Avidity Biosciences Stock Price Performance5 Day Performance-3.06%1 Month Performance+10.28%3 Month Performance+45.41%6 Month Performance+240.72%Year-To-Date Performance+194.03%1 Year Performance+147.53% Receive RNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avidity Biosciences and its competitors with MarketBeat's FREE daily newsletter Email Address Ad The Freeport SocietyBiden Nomination CANCELED?The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words?I believe I have the terrifying answer right here. RNA Stock Chart for Thursday, May, 30, 2024 RNA Chart by TradingView Avidity Biosciences Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/29/2024$26.32$26.61+1.10%$27.10$25.55793,988 shs$2.54 billion05/28/2024$27.45$26.32-4.12%$27.92$25.021.72 million shs$2.52 billion05/27/2024$27.45$27.45$28.39$27.01658,400 shs$2.63 billion05/24/2024$27.47$27.45-0.07%$28.39$27.01658,414 shs$2.63 billion05/23/2024$29.62$27.47-7.26%$30.00$27.381.40 million shs$2.63 billion05/22/2024$29.51$29.62+0.37%$30.84$29.30921,278 shs$2.83 billion Get the Latest News and Ratings for RNA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avidity Biosciences and its competitors with MarketBeat's FREE daily newsletter. 05/21/2024$29.24$29.51+0.92%$29.74$28.75722,440 shs$2.82 billion05/20/2024$29.50$29.24-0.88%$30.55$29.171.27 million shs$2.80 billion05/17/2024$28.72$29.50+2.72%$29.58$28.41895,405 shs$2.82 billion05/16/2024$29.51$28.72-2.68%$29.47$28.521.07 million shs$2.75 billion05/15/2024$28.91$29.51+2.08%$30.54$28.401.68 million shs$2.82 billion05/14/2024$26.02$28.91+11.11%$29.10$26.401.80 million shs$2.76 billion05/13/2024$25.96$26.02+0.23%$26.70$25.68783,718 shs$2.49 billion05/10/2024$27.10$25.96-4.21%$27.20$25.651.16 million shs$2.48 billion05/09/2024$26.06$27.10+3.99%$27.49$26.201.23 million shs$2.59 billion05/08/2024$25.39$26.06+2.64%$26.10$25.05804,068 shs$2.49 billion05/07/2024$26.33$25.39-3.57%$26.74$24.95682,046 shs$2.43 billion05/06/2024$26.45$26.33-0.45%$26.85$25.74693,694 shs$2.52 billion05/03/2024$25.58$26.45+3.40%$27.34$26.08641,486 shs$2.53 billion05/02/2024$25.80$25.58-0.85%$26.34$25.25558,447 shs$2.45 billion05/01/2024$24.13$25.80+6.92%$26.97$23.921.17 million shs$2.47 billion04/30/2024$24.70$24.13-2.31%$25.31$24.061.06 million shs$1.92 billion04/29/2024$24.36$24.70+1.40%$25.55$24.43640,595 shs$1.97 billion04/26/2024$23.83$24.36+2.22%$24.76$23.491.03 million shs$1.94 billion04/25/2024$25.09$23.83-5.02%$24.96$23.351.24 million shs$1.90 billion04/24/2024$25.14$25.09-0.20%$25.82$24.74559,786 shs$2.00 billion04/23/2024$24.16$25.14+4.06%$26.02$24.06859,065 shs$2.00 billion04/22/2024$22.73$24.16+6.29%$24.83$22.75911,772 shs$1.93 billion04/19/2024$23.04$22.73-1.35%$23.59$22.241.01 million shs$1.81 billion04/18/2024$23.55$23.04-2.17%$23.98$22.781.14 million shs$1.84 billion04/17/2024$23.91$23.55-1.51%$24.24$23.43716,621 shs$1.88 billion04/16/2024$23.91$23.91$24.20$23.25715,731 shs$1.91 billion04/15/2024$24.09$23.91-0.75%$24.44$23.62866,954 shs$1.91 billion04/12/2024$25.35$24.09-4.97%$25.50$23.91798,506 shs$1.92 billion04/11/2024$25.64$25.35-1.13%$25.99$25.19724,496 shs$2.02 billion04/10/2024$25.86$25.64-0.85%$25.80$24.451.04 million shs$2.04 billion04/09/2024$24.78$25.86+4.36%$25.86$24.51501,552 shs$2.06 billion04/08/2024$24.63$24.78+0.61%$25.24$24.00539,450 shs$1.98 billion04/05/2024$23.69$24.63+3.97%$24.75$22.94976,601 shs$1.96 billion04/04/2024$26.64$23.69-11.07%$27.17$21.562.59 million shs$1.89 billionThis unknown company solves the biggest issue with AI (Ad)Nvidia is the 800-lb gorilla in AI chips. But… it has a big problem. That's where one tiny company comes in. Discover why this company04/03/2024$26.87$26.64-0.86%$27.66$26.09949,862 shs$2.12 billion04/02/2024$26.40$26.87+1.78%$26.98$25.091.31 million shs$2.14 billion04/01/2024$25.52$26.40+3.45%$26.62$24.78930,460 shs$2.10 billion03/29/2024$25.52$25.52$25.95$24.501.23 million shs$2.03 billion03/28/2024$24.67$25.52+3.45%$25.85$24.511.23 million shs$2.03 billion03/27/2024$24.05$24.67+2.58%$25.61$23.701.85 million shs$1.97 billion03/26/2024$23.19$24.05+3.71%$24.39$23.50976,829 shs$1.92 billion03/25/2024$23.70$23.19-2.15%$24.20$22.851.10 million shs$1.85 billion03/22/2024$24.10$23.70-1.66%$24.61$23.47738,658 shs$1.89 billion03/21/2024$24.24$24.10-0.58%$24.83$23.781.08 million shs$1.92 billion03/20/2024$23.79$24.24+1.89%$24.81$23.451.29 million shs$1.93 billion03/19/2024$23.93$23.79-0.59%$24.70$23.201.34 million shs$1.90 billion03/18/2024$24.42$23.93-2.01%$25.12$23.661.98 million shs$1.91 billion03/15/2024$23.97$24.42+1.88%$24.94$23.731.68 million shs$1.95 billion03/14/2024$24.83$23.97-3.46%$26.24$23.502.39 million shs$1.91 billion03/13/2024$22.69$24.83+9.43%$24.91$22.251.49 million shs$1.98 billion03/12/2024$21.02$22.69+7.94%$22.78$20.911.22 million shs$1.81 billion03/11/2024$21.46$21.02-2.05%$21.67$20.801.03 million shs$1.68 billion03/08/2024$20.02$21.46+7.19%$21.55$20.341.33 million shs$1.71 billion03/07/2024$20.02$20.02$20.73$19.241.97 million shs$1.60 billion03/06/2024$19.14$20.02+4.60%$20.61$19.181.45 million shs$1.60 billion03/05/2024$18.86$19.14+1.48%$19.87$18.561.31 million shs$1.53 billion03/04/2024$20.11$18.86-6.22%$20.63$16.303.93 million shs$1.51 billion03/01/2024$18.30$20.11+9.89%$20.35$18.382.43 million shs$1.49 billion02/29/2024$15.26$18.30+19.92%$19.46$17.713.96 million shs$1.36 billion Related Companies: Dyne Therapeutics Stock Chart MorphoSys Stock Chart Maravai LifeSciences Stock Chart Amicus Therapeutics Stock Chart Xenon Pharmaceuticals Stock Chart PTC Therapeutics Stock Chart Corcept Therapeutics Stock Chart Merus Stock Chart TG Therapeutics Stock Chart Summit Therapeutics Stock Chart Receive RNA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Avidity Biosciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RNA) was last updated on 5/30/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersBiden Nomination CANCELED?The Freeport SocietyThe 7th Trillion Dollar Company?The Oxford ClubThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarGold Set to EXPLODE!Gold Safe Exchange[Urgent!] Generational Wealth GameplanCrypto 101 MediaGet out of dollars—get into America’s new money insteadStansberry ResearchThis unknown company solves the biggest issue with AIManward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avidity Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.